Bevacizumab 2.5 mg/0.1 mL recall: Labeling Error
Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes…
Why was Bevacizumab 2.5 mg/0.1 mL recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 66377, Exp. Date: 06/28/2023. Syringe may be labeled incorrectly as lot# 66316
- Product
- Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes…
- Recalling firm
- Pine Pharmaceuticals, LLC
- Quantity
- 932 syringes
- Distribution
- Nationwide in the USA
- Recall date
- April 19, 2023
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)